Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

aap Implantate AG issues FY 2014 Q2 outlook; reaffirms FY 2014 outlook


Thursday, 15 May 2014 02:07pm EDT 

aap Implantate AG:Expects sales for the second quarter of FY 2014 to be between 7.6 million and 8.2 million euros(Q2 2013 (excl. EMCM): 6.6 million euros).Expects EBITDA for the second quarter of FY 2014 to be between 1.0 million and 1.5 million euros (Q2 2013 (excl. EMCM): 0.2 million euros).Reaffirms the sales and EBITDA outlook for the full year of 2014 with sales of 35 million euros and an EBITDA of between 5 million and 6 million euros. 

Company Quote

2.83
0.031 +1.11%
15 Aug 2014